Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.
Screenshot error
Open in browserReport Problem
Clouds background image

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page

  1. Check
    60 days ago
    Change Detected
    Summary
    The study has expanded to include 343 locations across various states and countries, with new results expected to be posted on January 22, 2025, while previous results and locations have been removed.
    Difference
    99%
    Check dated 2025-01-22T22:08:49.000Z thumbnail image
  2. Check
    67 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-15T18:24:49.000Z thumbnail image
  3. Check
    74 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-08T15:44:47.000Z thumbnail image
  4. Check
    82 days ago
    Change Detected
    Summary
    Results have been submitted, replacing the previous status of no results posted.
    Difference
    0.1%
    Check dated 2025-01-01T10:18:34.000Z thumbnail image
  5. Check
    96 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-18T04:36:42.000Z thumbnail image
  6. Check
    103 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-12-10T23:44:50.000Z thumbnail image

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.